MRNS is currently covered by 9 analysts
Marinus Pharmaceuticals's activity chart (see below) currently has 46 price targets and 72 ratings on display. The stock rating distribution of MRNS is 92.86% BUY and 7.14% HOLD.
Analysts' price targets on this stock were met 5.6% of the time, taking 44.43 days on average.
Highest price target for MRNS is $10, Lowest price target is $1.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 24-Sep-2024.
Currently out of the existing stock ratings of MRNS, 39 are a BUY (92.86%), 3 are a HOLD (7.14%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$13
$13
2 years 1 months 24 days ago
(24-Sep-2024)
0/7 (0%)
$11.1 (584.21%)
Hold
$6
$9
2 years 1 months 25 days ago
(23-Sep-2024)
1/6 (16.67%)
$4.31 (255.03%)
5
Buy
$13
2 years 3 months 3 days ago
(14-Aug-2024)
1/6 (16.67%)
$6.1 (88.41%)
309
Buy
$11
$11
2 years 3 months 3 days ago
(14-Aug-2024)
0/15 (0%)
$9.9 (900.00%)
Buy
$3
$21
2 years 7 months 2 days ago
(15-Apr-2024)
2/10 (20%)
$1.7 (130.77%)
247
What is MRNS (Marinus Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on MRNS (Marinus Pharmaceuticals)?
Which analyst has the most public recommendations on MRNS (Marinus Pharmaceuticals)?
Which analyst is the currently most bullish on MRNS (Marinus Pharmaceuticals)?
Which analyst is the currently most reserved on MRNS (Marinus Pharmaceuticals)?